Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

SECAUCUS, N.J. , Aug. 28, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York .

SECAUCUS, N.J. , Aug. 15, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on October 21, 2019 to shareholders of record

Two new companies join the GDN, expanding this novel worldwide network of leading diagnostics service providers With nine members spanning the globe, the GDN has a presence in countries covering two-thirds of the world's population, and over 90% of the global pharmaceutical market SECAUCUS, N.J.

SECAUCUS, N.J. , July 17, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has been named to the 2019 Disability Equality Index (DEI) "Best Places to Work for Disability Inclusion" by Disability:IN and the

SECAUCUS, N.J. , July 9, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2019 results on Tuesday, July 23, 2019 , before the market opens.

Participants decreased diabetes risk by 2.8 percent on average and 31 percent lost five percent or more of body weight after completing at least nine lessons in program SECAUCUS, N.J. , June 17, 2019 /PRNewswire/ -- Individuals with prediabetes who participate in an employer-sponsored digital

As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial Both the Quest Med Fusion 50SEQ cancer panel and IBM Watson Genomics from

SECAUCUS, N.J. , May 14, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on July 22, 2019 to shareholders of record

SECAUCUS, N.J. , May 13, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the UBS Global Healthcare Conference in New York. Steve Rusckowski , Chairman, President and CEO

- First quarter revenues of $1.89 billion, up 0.4% from 2018 - First quarter reported diluted EPS of $1.20, down 5.4% from 2018; and adjusted diluted EPS of $1.40, down 7.9% from 2018 - Cash provided by operations was $275 million, up 53.4% from 2018 - Outlook for full-year 2019 remains unchanged.

SECAUCUS, N.J. , April 22, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it was selected by Forbes as one of America's Best Large Employers of 2019. Quest was among one of only fifteen

Available nationwide, the new services link consumer-initiated testing with medical oversight and counsel to help combat the nation's record rate of STDs SECAUCUS, N.J. , April 18, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services,

Analysis of more than ten million workplace drug test results shows increases in marijuana positivity across nearly all employee testing categories Increases in post-accident positivity in the general U.S. workforce outpace those for all other testing reasons, including pre-employment screening

SECAUCUS, N.J. , April 4, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2019 results on Tuesday, April 23, 2019 , before the market opens.

SECAUCUS, N.J. , March 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $500 million aggregate principal amount of its 4.200% senior notes due 2029 under the

SECAUCUS, N.J. , March 1, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on April 22, 2019 to shareholders of record

SECAUCUS , N.J. and WARNER ROBINS, Ga. , Feb. 20, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through